Tsh Biopharmoration Stock Book Value Per Share
| 8432 Stock | TWD 61.00 0.30 0.49% |
tsh biopharmoration fundamentals help investors to digest information that contributes to Tsh Biopharmoration's financial success or failures. It also enables traders to predict the movement of Tsh Stock. The fundamental analysis module provides a way to measure Tsh Biopharmoration's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tsh Biopharmoration stock.
Tsh |
tsh biopharmoration Company Book Value Per Share Analysis
Tsh Biopharmoration's Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
Current Tsh Biopharmoration Book Value Per Share | 27.67 X |
Most of Tsh Biopharmoration's fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, tsh biopharmoration is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
| Competition |
In accordance with the recently published financial statements, the book value per share of tsh biopharmoration is about 27.674 times. This is 1727.88% lower than that of the Healthcare sector and 115.03% higher than that of the Drug Manufacturers - Major industry. The book value per share for all Taiwan stocks is 98.57% higher than that of the company.
Tsh Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tsh Biopharmoration's direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tsh Biopharmoration could also be used in its relative valuation, which is a method of valuing Tsh Biopharmoration by comparing valuation metrics of similar companies.Tsh Biopharmoration is rated second in book value per share category among its peers.
Tsh Fundamentals
| Return On Equity | 0.0635 | |||
| Return On Asset | 0.0387 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | 0.16 % | |||
| Current Valuation | 1.17 B | |||
| Shares Outstanding | 38.4 M | |||
| Shares Owned By Insiders | 64.94 % | |||
| Price To Earning | 56.63 X | |||
| Price To Book | 1.77 X | |||
| Price To Sales | 4.22 X | |||
| Revenue | 413.48 M | |||
| Gross Profit | 247.36 M | |||
| EBITDA | 71.41 M | |||
| Net Income | 47.11 M | |||
| Cash And Equivalents | 708.28 M | |||
| Cash Per Share | 18.36 X | |||
| Total Debt | 7.01 M | |||
| Debt To Equity | 0.60 % | |||
| Current Ratio | 5.36 X | |||
| Book Value Per Share | 27.67 X | |||
| Cash Flow From Operations | 68.71 M | |||
| Earnings Per Share | 1.78 X | |||
| Number Of Employees | 80 | |||
| Beta | -0.0266 | |||
| Market Capitalization | 1.78 B | |||
| Total Asset | 1.17 B | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 3.54 % | |||
| Net Asset | 1.17 B | |||
| Last Dividend Paid | 1.5 |
About Tsh Biopharmoration Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze tsh biopharmoration's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tsh Biopharmoration using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of tsh biopharmoration based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Tsh Biopharmoration
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tsh Biopharmoration position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tsh Biopharmoration will appreciate offsetting losses from the drop in the long position's value.Moving against Tsh Stock
| 0.51 | 4102 | Yung Zip Chemical | PairCorr |
| 0.45 | 3019 | Asia Optical | PairCorr |
| 0.39 | 2884 | ESUN Financial Holding | PairCorr |
| 0.35 | 4108 | Phytohealth Corp | PairCorr |
| 0.31 | 4571 | Khgears International | PairCorr |
The ability to find closely correlated positions to Tsh Biopharmoration could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tsh Biopharmoration when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tsh Biopharmoration - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling tsh biopharmoration to buy it.
The correlation of Tsh Biopharmoration is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tsh Biopharmoration moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if tsh biopharmoration moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tsh Biopharmoration can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Tsh Stock Analysis
When running Tsh Biopharmoration's price analysis, check to measure Tsh Biopharmoration's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tsh Biopharmoration is operating at the current time. Most of Tsh Biopharmoration's value examination focuses on studying past and present price action to predict the probability of Tsh Biopharmoration's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tsh Biopharmoration's price. Additionally, you may evaluate how the addition of Tsh Biopharmoration to your portfolios can decrease your overall portfolio volatility.